Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947"

Cancers (Basel). 2023 Feb 13;15(4):1187. doi: 10.3390/cancers15041187.

¹ Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT 84112, USA.
² Department of Internal Medicine, Hurley Medical Center, Michigan State University, Flint, MI 48503, USA.
³ Division of Gastroenterology & Hepatology, CHI Health Creighton University Medical Center, Omaha, NE 68131, USA.
⁴ Health Science Library, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA.
⁵ Department of Internal Medicine, Mather Hospital, Northwell Health, Port Jefferson, NY 11777, USA.
⁶ Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, Sector 12, Chandigarh 160012, India.
⁷ Polistudium SRL, 20135 Milan, Italy.
⁸ Division of Medical Oncology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
⁹ Gastroenterology Unit, Department of Surgical and Medical Sciences, University of Foggia, 71122 Foggia, Italy.

Abstract

We thank Dr. Lissing and colleagues for providing us with these helpful comments [...].

This research received no external funding.